RISE Forum

The RISE Forum: A Research, Innovation, & Science Exchange

Share Ideas. Expand boundaries. Explore new frontiers.

The RISE Forum is a comprehensive, expert-led program designed to equip interventional oncologists, scientists, and clinical investigators with the tools and knowledge to advance impactful research across the translational spectrum. From foundational laboratory platforms to clinical trial design and next-generation innovations, this immersive course spans the critical elements necessary for driving discovery and accelerating clinical progress in interventional oncology.

SIO aims to advance the levels of evidence in interventional oncology (IO), supporting access to preclinical and clinical research efforts with this six-hour program, hosted on Wednesday, 4 February 2026. This innovative research forum will be the first of its kind to be organized by a major radiology society. Structured into thematic sections — Preclinical Foundations, Clinical Trial Design, and Emerging Technologies — this course will emphasize practical learning through expert lectures, roundtable discussions, and debate-style learning. Participants will explore how to select and apply relevant models, design robust clinical studies with meaningful endpoints, and critically analyze both successful and failed trials to inform future efforts. The course also highlights innovative frontiers including theranostics, biologic delivery systems, and machine learning integration.

Attendees can expect a comprehensive half-day course presented by leading interventional oncology researchers, where they will engage with translational research models, adopt strategies for bridging the preclinical-clinical divide, and explore considerations for IO-specific trial designs.

Program

Schedule information is subject to change. Additional faculty details to be added as invitations are accepted. Last updated 20 June 2025.

Wednesday, 4 February 2026
Time	Session
11:30 a.m. - 12:00 p.m.	Lunch
12:00 - 1:00 p.m.	In Vitro & In Vivo Models for Translational Research Moderated by Rony Avritscher, MD, FSIR and Terence P. Gade, MD, PhD Opening Remarks & Masterclass Overview, presented by Rony Avritscher, MD, FSIR How to Start a Lab and Negotiate Your Package: the Story of the PIGI Lab, presented by Terence P. Gade, MD, PhD Rodent Models in Interventional Oncology: Unlocking Mechanisms and Enabling High-Throughput Hypothesis Testing, presented by Khashayar Farsad, MD, PhD Large Animal Models in Interventional Oncology: Bridging the Gap to Clinical Application and Advancing Device Development presented by Luke R. Wilkins, MD, FSIR
1:15 - 2:15 p.m.	Cellular & Molecular Mechanisms Moderated by Lynn J. Savic, MD and S. Nahum Goldberg, MD, FSIR, FCIRSE 2D and 3 D Culture Models: Applications in Testing Combination Approaches, presented by Glauco Souza, MD Immunological Consequences of Thermal Ablation & Endovascular Therapy, presented by Lynn J. Savic, MD Potentiating the Efficacy of Endovascular Locoregional Therapy: Enabling Synergy and Overcoming Resistance, presented by Christopher D. Malone, MD Roundtable Discussion: Bridging the Preclinical-Clinical Divide, facilitated by S. Nahum Goldberg, MD, FSIR, FCIRSE, in conversation with Khashayar Farsad, MD, PhD, Bradford J. Wood, MD, and Lynn J. Savic, MD
2:30 - 3:30 p.m.	Clinical Trials in Interventional Oncology (Part 1) Moderated by Michael C. Soulen, MD, FSIR, FCIRSE and Irene Bargellini, MD, Prof From Bench to First-in-Human: Navigating the Regulatory Landscape presented by Fred Lee, MD Endpoints That Matter: Selection of Clinically Meaningful Outcomes in IO Trials, presented by Michael C. Soulen, MD, FSIR, FCIRSE Statistical Considerations for IO-Specific Trial Designs, presented by Christine B. Peterson, PhD Roundtable Discussion: Addressing Challenges in IO Trial Design, facilitated by Michael C. Soulen, MD, FSIR, FCIRSE, in conversation with Irene Bargellini, MD, Prof, and Richard Finn, MD
3:45 - 4:45 p.m.	Clinical Trials in Interventional Oncology (Part 2) Moderated by Jens Ricke, MD and Philippe L. Pereira, MD Rational Design of IO-Immunotherapy Combinations, presented by Jens Ricke, MD Theranostic Approaches: Combined Diagnostic and Radioembolization, presented by Liliana Violante, MD Critical Gaps in Clinical Data: Looking Toward the Future, presented by Amy Deipolyi, MD, PhD, FSIR Roundtable Discussion: Evolving Trial Evidence and Clinical Practice Changes, facilitated by Jens Ricke, MD, in conversation with Amy Deipolyi, MD, PhD, FSIR, Philippe L. Pereira, MD, and Michael C. Soulen, MD, FSIR, FCIRSE
5:00 - 6:00 p.m.	Industry Developments and Innovation Pipeline Moderated by Isabel G. Newton, MD, PhD, Julius Chapiro, MD, PhD, and Muneeb Ahmed, MD, FSIR Abscopal Effects: Facts and Fiction, presented by Isabel G. Newton, MD, PhD Integrating machine learning into future trials for Embolotherapies, presented by Julius Chapiro, MD, PhD The Role of LRT in Emerging Biological Therapies for Cancer, presented by Jason Chiang, MD, PhD Trial Failures: What Have We Learned? Roundtable Discussion: Clinical Integration of Novel Technologies, presented by Muneeb Ahmed, MD, FSIR Roundtable Discussion: From Concept of Commercialization, presented by Glauco Souza, MD